genoptix soars in debut shares of laboratory services company genoptix inc became the latest in a series of health care related companies to post large first day trading gains increasing from its initial public offering price shares were at &# yesterday in p m nasdaq stock market composite trading up from their ipo price of &# five million shares were sold at a price above its expected &# to &# range the carlsbad calif company provides diagnostic lab services for doctors who are assessing cancer patients genoptix reported revenue of &# million in the first half more than double from a year earlier and net income of &# million compared with a net loss of &# million a year earlier "right now what we have is a shortage of companies that actually have revenues and all that other good stuff " said steve brozak a biotech and medical devices analyst who is president of wbb securities lehman brothers holdings inc was the book running manager on the offering 
